A comprehensive view of Illnesses / Symptoms / Conditions. This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.
Pierre Fabre Laboratories' treatment for advanced NSCLC receives positive CHMP opinion; targeting BRAFV600E mutation, awaiting European Commission approval
Published:
July 26, 2024
by Industry Intelligence Inc.
|
Novartis Files United States Patent Application for Methods for the Treatment of Osteoarthritis
Published:
July 22, 2024
by Pharmaceutical Patent News
|
Regeneron Pharmaceuticals Files United States Patent Application for Treatment of B27-Negative Uveitis with Inositol Polyphosphate Multikinase (IPMK) Therapeutic Agents or Indoleamine 2,3-Dioxygenase 2 (IDO2) Agonists
Published:
July 22, 2024
by Pharmaceutical Patent News
|
Eli Lilly and Company Secures Patent for AHR Agonists
Published:
July 20, 2024
by Pharmaceutical Patent News
|
AstraZeneca champions early lung cancer detection in Australia, CLL education in the UK, and rare disease support in Hong Kong; lung cancer screening starts July 2025 in Australia
Published:
July 18, 2024
by Industry Intelligence Inc.
|
Ask us about our R&D/Patents market view